腫瘍病理鑑別診断アトラス 前立腺癌

出版社: 文光堂
著者:
発行日: 2009-11-18
分野: 臨床医学:基礎  >  臨床病理学
ISBN: 9784830622250
シリーズ: 腫瘍病理鑑別診断アトラス
電子書籍版: 2009-11-18 (第1版第3刷)
書籍・雑誌
≪全国送料無料でお届け≫
発送目安:8~14営業日

13,200 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

13,200 円(税込)

商品紹介

本書は病理診断標準化のため,癌取扱い規約とWHO分類を踏まえ,日常診療でよく遭遇する疾患を中心に取り上げ,その鑑別ポイントを「二層性パターン」「Gleason score」「櫛状構造」などのキーワードから読み解くアトラスである。微小癌についてや治療効果判定,ノモグラムの実情など,臨床との連携についても言及する。

目次

  • 前立腺癌

    ―目次―

    第1部 検鏡前の確認事項
     I.病理標本の取扱い方
     II.前立腺の解剖学
     III.病理組織分類の現状

    第2部 組織型と診断の実際
     I.腺癌
     II.稀な腺癌
     III.その他の癌
     IV.間質性腫瘍および上皮間質性腫瘍
     V.Prostatic intraepithelial neoplasia(PIN)
     VI.前立腺の良性病変

    第3部 鑑別ポイント
     I.二層性パターンの判定法
     II.Gleason分類とGleason scoreの実際
     III.小腺房状および篩状構造を示す病変の鑑別
     IV.クリスタロイド,核小体の評価
     V.尿路上皮癌(移行上皮癌)との鑑別

    第4部 臨床との連携
     I.微小癌
     II.病理診断報告書の記載
     III.病理組織学的治療効果判定
     IV.臨床病期の決定と治療方針

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1部 検鏡前の確認事項

P.8 掲載の参考文献
1) Epstein JL, Allsbrook WC Jr, Amin MB et al : The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29 : 1228-1242, 2005
2) Epstein JL, Walsh PC, Carmichael M et al : Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostatic cancer. JAMA 271 : 368-374, 1994
3) 日本泌尿器科学会・病理学会編 : 前立腺癌取扱い規約, 第3版. 金原出版, 2001, pp50-51
4) 遠藤希之, 金泰乙, 齋藤誠一 : 前立腺癌の診断のための検体処理・標本作製. 病理と臨床 23 (臨増) : 379-382, 2005
5) 大保亮一 : 泌尿器科臨床病理シリーズ・前立腺 (II). インターメディカ, 2004, pp2-3
6) 都築豊徳, 前田永子 : 前立腺. 外科病理マニュアル. 病理と臨床 26 (臨増) : 291-296, 2008
7) Hall GS, Kramer CE, Epstein JI : Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Am J Surg Pathol 16 : 315-324, 1992
8) Murphy WM, Dean PJ, Brasfield JA et al : Incidental carcinoma of the prostate. How much sampling is adequate? Am J Surg Pathol 10 : 170-174, 1986
9) Tropkov K, Thompson J, Yilmaz A : How much tissue sampling is required when unsuspected minimal prostate carcinoma is identified on transurethral resection? Arch Pathol Lab Med 132 : 1313-1316, 2008
P.14 掲載の参考文献
1) Walsh PC, Epstein JI, Lowe FC : Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle. J Urol 138 : 823-827, 1987
2) Villers A, McNeal JE, Redwine EA et al : The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 142 : 763-768, 1989
3) 大保亮一, 吉田修, 荒井陽一 : 泌尿器科臨床病理学, インターメディカ, 2008, pp12-14, pp19-21
4) Lowsley OS : The development of the human prostate gland with reference to the development of other structures at the neck of the urinary bladder. Am J Anat 13 : 299-349, 1912
5) McNeal JE : Prostate. in Mills SE (ed) : "Histology for Pathologists", 3rd ed, Lippincott-Raven, Philadelphia, 2007, pp923-942
6) 日本泌尿器科学会・日本病理学会編 : 前立腺取扱い規約, 第3版, 金原出版, 2001
7) Ayala AG, Ro JY, Babaian R et al : The prostatic capsule : does it exist? Am J Surg Pathol 13 : 21-27, 1989
8) Humphrey PA : Prostate gland development and anatomic structure. in "Prostate Pathology", American Society for Clinical Pathology, Chicago, 2003, pp2-29
10) Huang J, Yao JL, Sant'Agnese PA : Neuroendocrine differentiation in prostate cancer. in Kirby RS, Partin AW, Feneley M et al (eds) : "Prostate Cancer. Principles and Practice", Taylor and Francis, London, 2006, pp143-150
P.19 掲載の参考文献
1) 日本泌尿器科学会, 日本病理学会編 : 前立腺癌取扱い規約, 第2版, 金原出版, 1985
2) 日本泌尿器科学会, 日本病理学会編 : 前立腺癌取扱い規約, 第3版, 金原出版, 2001
3) Histological Typing of Prostate Tumors, WHO Blue Book, 2002
4) Tumor of the Urinary System and Male Genital Organs, WHO, IARC, Lyon, 2004
5) 小山徹也, 瀬川篤記 : 病理診断-Gleason分類とWHO分類-. 泌尿器外科 14 : 627-630, 2001
6) 黒川公平, 小山徹也, 山中英壽 : 「前立腺癌取扱い規約 第3版」とその問題点. 臨泌 57 (増刊) : 259-263, 2003

第2部 組織型と診断の実際

P.39 掲載の参考文献
1) Epstein JI : Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol 26 : 223-229, 1995
3) Baisden BL, Kahane H, Epstein JI : Perineural invasion, mucinous fibroplasia, and glomerulations : diagnostic features of limited cancer on prostate needle biopsy. Am J Surg Pathol 23 : 918-924, 1999
5) Brawer MK, Peehl DM, Stamey TA et al : Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 45 : 3663-3667, 1985
6) Jiang Z, Woda BA, Rock KL et al : P504S : a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 25 : 1397-1404, 2001
7) Hameed O, Humphrey PA : Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol 22 : 88-104, 2005
10) Humphrey PA, Kaleem Z, Swanson PE et al : Pseudohyperplastic prostatic adenocarcinoma. Am J Surg Pathol 22 : 1239-1246, 1998
11) Nelson RS, Epstein JI : Prostatic carcinoma with abundant xanthomatous cytoplasm. Foamy gland carcinoma. Am J Surg Pathol 20 : 419-426, 1996
12) Egan AJ, Lopez-Beltran A, Bostwick DG : Prostatic adenocarcinoma with atrophic features : malignancy mimicking a benign process. Am J Surg Pathol 21 : 931-935, 1997
15) Cina SJ, Silberman MA, Kahane H et al : Diagnosis of Cowper's glands on prostate needle biopsy. Am J Surg Pathol 21 : 550-555, 1997
18) Skinnider BF, Oliva E, Young RH et al : Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma : a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma. Am J Surg Pathol 28 : 701-705, 2004
21) Iczkowski KA, MacLennan GT, Bostwick DG : Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies : clinical significance in 33 cases. Am J Surg Pathol 21 : 1489-1495, 1997
22) Epstein JI, Allsbrook WC Jr, Amin MB et al : The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29 : 1228-1242, 2005
23) Albertsen PC, Hanley JA, Barrows GH et al : Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97 : 1248-1253, 2005
P.48 掲載の参考文献
1) Bostwick DJ, Kindrachuk RW, Rouse RV : Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings. Am J Surg Pathol 9 : 595-609, 1985
2) Epstein JI, Woodruff JM : Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases. Cancer 57 : 111-119, 1986
3) Greene LF, Farrow GM, Ravits JM : Prostatic adenocarcinoma of ductal origin. J Urol 121 : 303-305, 1979
4) Oxley JD, Abbott AD, Gillatt DA et al : Ductal adenocarcinoma of the prostate : a clinicopathological and immunohistochemical study. Br J Urol 81 : 109-115, 1998
5) Young BW, Lagios MD : Endometrial (papillary) carcinoma of the prostatic utricle-response to orchiectomy. A case report. Cancer 32 : 1293-1300, 1973
6) Zaloudek C, Williams JW, Kempson RL : "Endometrial" adenocarcinoma of the prostate : a distinctive tumor of probable prostatic origin. Cancer 37 : 2255-2262, 1976
7) Epstein JI, Allsbrook WC Jr, Amin MB et al : The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29 : 1228-1242, 2005
8) Hameed O, Humphrey PA : Stratified epithelium in prostatic adenocarcinoma : A mimic of high-grade prostatic intraepithelial neoplasia. Mod Pathol 19 : 899-906, 2006
9) Tavora F, Epstein JI : High-grade prostatic intraepithelial neoplasia like adenocarcinoma of the prostate : a clinicopathological study of 28 cases. Am J Surg Pathol 32 : 1060-1067, 2008
10) Cohen RJ, McNeal JE, Baillie T : Patterns of differentiation and proliferation in intraductal carcinoma of the prostate : significance for cancer progression. Prostate 43 : 11-19, 2000
11) McNeal JE, Yemoto CE : Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol 20 : 802-814, 1996
12) Guo C, Epstein JI : Intraductal carcinoma of the prostate on needle biopsy : histologic features and clinical significance. Mod Pathol 19 : 1528-1530, 2006
13) Olian BR, Kahane H, Epstein JI : A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy. Am J Surg Pathol 25 : 794-801, 2001
14) Young RH : Non-neoplastic and tumor-like abnormalities. in Young RH (ed) : Pathology of the Urinary Bladder, Churchill Livingstone, New York, 1989, pp36-37
16) Ro JY, Grignon DJ, Ayala AG et al : Mucinous adenocarcinoma of the prostate : histochemical and immunohistochemical studies. Hum Pathol 21 : 593-600, 1990
17) Tran KP, Epstein JI : Mucinous adenocarcinoma of urinary bladder type arising from the prostatic urethra. Distinction from mucinous adenocarcinoma of the prostate. Am J Surg Pathol 20 : 1346-1350, 1996
18) Epstein JI, Kuhajda FP, Liebberman PH : Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder. Hum Pathol 17 : 939-942, 1986
19) Heyderman E, Brown BM, Richadson TC : Epithelial markers in prostatic, bladder, and colorectal cancer : an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase. J Clin Pathol 37 : 1363-1369, 1984
20) Minkowitz G, Peterson P, Godwin TA : A histochemical and immunohistochemical study of adenocarcinomas involving urinary bladder. Mod Pathol 3 : 68A, 1990
22) Owens CL, Epstien JI, Netto GJ : Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples : the role of morphology and immunohistochemistry. Arch Pathol Lab Med 131 : 599-603, 2007
23) Ro JY, el-Naggar A, Ayala AG et al : Signet-ring-cell carcinoma of the prostate. Electron microscopic and immunohistochemical studies of eight cases. Am J Surg Pathol 12 : 453-460, 1988
24) Hejka AG, England DM : Signet ring cell carcinoma of prostate. Immunohistochemical and ultrastructural study of a case. Urology 34 : 155-158, 1989
25) Uchijima Y, Ito H, Takahashi M et al : Prostate mucinous adenocarcinoma with signet ring cells. Urology 36 : 267-268, 1990
26) Frankel K, Craig JR : Adenoid cystic carcinoma of the prostate. Report of a case. Am J Clin Pathol 62 : 639-645, 1974
P.60 掲載の参考文献
1) Humphrey PA : Prostate Pathology, ASCP Press, Chicago, 2003, pp410-414
3) Goebbels R, Amberger L, Wernert N et al : Urothelial carcinoma of the prostate. Appl Pathol 3 : 242-254, 1985
4) Oliai BR, Kahane H, Epstein JI : A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy. Am J Surg Pathol 25 : 794-801, 2001
8) Ende N, Woods LP, Shelley HS : Carcinoma originating in ducts surrounding the prostatic urethra. Am J Clin Pathol 40 : 183-189, 1963
10) Mott LJ : Squamous cell carcinoma of the prostate : report of 2 cases and review of the literature. J Urol 121 : 833-835, 1979
11) Munoz F, Franco P, Ciammella P et al : Squamous cell carcinoma of the prostate : long-term survival after combined chemo-radiation. Radiat Oncol 2 : 15 (http://www.rojournal.com/content/2/1/15)
12) Parwani AV, Kronz JD, Genega EM et al : Prostate carcinoma with squamous differentiation : an analysis of 33 cases. Am J Surg Pathol 28 : 651-657, 2004
13) Little NA, Wiener JS, Walther PJ et al : Squamous cell carcinoma of the prostate : 2 cases of a rare malignancy and review of the literature. J Urol 149 : 137-139, 1993
14) Accetta PA, Gardner WA : Adenosquamous carcinoma of prostate. Urol 22 : 73-75, 1983
15) Sieracki JC : Epidermoid carcinoma of the human prostate : report of three cases. Lab Invest 4 : 232-240, 1955
17) Humphrey PA : Prostate Pathology, ASCP Press, Chicago, 2003, pp406-408
19) Humphrey PA : Prostate Pathology, ASCP Press, Chicago, 2003, pp414-419
24) Yao JL, Madeb R, Bourne P et al : Small cell carcinoma of the prostate : an immunohistochemical study. Am J Surg Pathol 30 : 705-712, 2006
25) Palmgren JS, Karavadia SS, Wakefield MR : Unusual and under appreciated : small cell carcinoma of the prostate. Semin Oncol 34 : 22-29, 2007
29) Evans AJ, Humphrey PA, Belani J et al : Large cell neuroendocrine carcinoma of prostate : a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer. Am J Surg Pathol 30 : 684-693, 2006
30) Garabedian EM, Humphrey PA, Gordon JI : A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. Proc Natl Acad Sci USA 95 : 15382-15387, 1998
32) Frankel K, Craig JR : Adenoid cystic carcinoma of the prostate. Report of a case. Am J Clin Pathol 62 : 639-645, 1974
34) Randolph TL, Amin MB, Ro JY et al : Histologic variants of adenocarcinoma and other carcinomas of prostate : pathologic criteria and clinical significance. Mod Pathol 10 : 612-629, 1997
35) Tan P, Billis A : Basal cell carcinoma. in Eble J, Sauter G, Epstein J et al (eds) : "WHO Classification of Tumours : Pathology and Genetics of the Urinary System and Male Genital Organs", IARC Press, Lyon, 2004, p206
36) McKenney JK, Amin MB, Srigley JR et al : Basal cell proliferations of the prostate other than usual basal cell hyperplasia : a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification. Am J Surg Pathol 28 : 1289-1298, 2004
37) Iczkowski KA, Ferguson KL, Grier DD et al : Adenoid cystic/basal cell carcinoma of the prostate : clinicopathologic findings in 19 cases. Am J Surg Pathol 27 : 1523-1529, 2003
39) Young RH, Srigley JR, Amin MB et al : Atlas of Tumor Pathology. Tumors of the Prostatic Glands, Seminal Vesicles, Male Urethra, and Penis. AFIP, Washington DC, 2000, p242
P.67 掲載の参考文献
1) Sexton WJ, Lance RE, Reyes AO et al : Adult prostate sarcoma : the M.D. Anderson Cancer Center Experience. J Urol 166 : 521-525, 2001
2) Eble JN, Sauter G, Epstein JI et. al : World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, 2004
3) Gaudin PB, Rosai J, Epstein JI : Sarcomas and related proliferative lesions of specialized prostatic stroma : a clinicopathologic study of 22 cases. Am J Surg Pathol 22 : 148-162, 1998
4) Herawi M, Epstein JI : Specialized stromal tumors of the prostate : a clinicopathologic study of 50 cases. Am J Surg Pathol 30 : 694-704, 2006
5) Bostwick DG, Hossain D, Qian J et al : Phyllodes tumor of the prostate : long-term followup study of 23 cases. J Urol 172 : 894-899, 2004
7) Gaudin PB, Rosai J, Epstein JI : Sarcomas and related proliferative lesions of specialized prostatic stroma [letters to the Editor]. Am J Surg Pathol 23 : 243-244, 1999
8) Bostwick DG, Cheng L (eds) : Urologic Surgical Pathology (2nd ed), Mosby Elsevier, Edinburgh, 2008
10) Cheville JG, Dundore PA, Nascimento AG et al : Leiomyosarcoma of the prostate. Report of 23 cases. Cancer 76 : 1422-1427, 1995
11) Kelley TW, Borden EC, Goldblum JR : Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas : an immunohistochemical study. Appl Immunohistochem Mol Morphol 12 : 338-341, 2004
13) Nabi G, Dinda AK, Dogra PN : Primary embryonal rhabdomyosarcoma of prostate in adults : diagnosis and management. Int Urol Nephrol 34 : 531-534, 2002
P.72 掲載の参考文献
1) Kastendieck H, Altenahr E, Husselmann H : Carcinoma and dysplastic lesions of the prostate. Z Krebsforsch 88 : 33-54, 1976
2) Helpap B : The biological significance of atypical hyperplasia of the prostate. Virchows Arch A 387 : 307-317, 1980
3) McNeal JE, Bostwick DG : Intraductal dysplasia : a premalignant lesion of the prostate. Hum Pathol 17 : 64-71, 1986
4) Kovi J, Mostofi FK, Heshmat MY et al : Large acinar atypical hyperplasia and carcinoma of the prostate. Cancer 61 : 555-561, 1988
5) Bostwick DG : Prostatic intraepithelial neoplasia (PIN). Urology 34 : 16-22, 1989
6) Bostwick DG, Srigley J, Grignon D et al : Atypical adenomatous hyperplasia of the prostate : morphologic criteria for its distinction from well differentiated carcinoma. Hum Pathol 24 : 819-832, 1993
7) Eble JN, Sauter G, Epstein JI et al : World Health Organization Classification of tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon, 2004
10) Mostofi FK, Sesterhenn IA, Davis CJ : Histological Typing of Prostate Tumors, World Health Organization International Histological Classification of the Tumours (2nd ed), Springer, Berlin, 2002
11) 日本泌尿器科学会, 日本病理学会 (編) : 前立腺癌取扱い規約 (第3版), 金原出版, 2001
13) 鷹橋浩幸 : 前立腺生検におけるPINATYPの意義. 病理と臨床 24 : 1118-1119, 2006
16) Hameed O, Humphrey PA : Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol 22 : 88-104, 2005
21) Ayala AG, Srigley JR, Ro JY et al : Clear cell cribriform hyperplasia of prostate. Report of 10 cases. Am J Surg Pathol 10 : 665-671, 1986
22) Chan TY, Epstein JI : Patient and urologist driven second opinion of prostate needle biopsies. J Urol 174 : 1390-1394, 2005
23) Amin MB, Ro JY, Ayala AG : Prostatic intraepithelial neoplasia : relationship to adenocarcinoma of the prostate. Pathol Annu 29 : 1-30, 1994
25) Bishara T, Ramnani DM, Epstein JI : High-grade prostatic intraepithelial neoplasia on needle biopsy : risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern. Am J Surg Pathol 28 : 629-633, 2004
P.93 掲載の参考文献
1) Bostwick DG, Quian J, Hossain D : Non-neoplastic diseases of the prostate. in Bostwick DG, Cheng L (eds) : "Urologic Surgical Pathology (2nd ed)", Mosby Elsevier, 2008, pp382-440
2) Epstein JI, Netto GJ : Biopsy Interpretation of the Prostate (4th ed), Lippincott Williams & Wilkins, Philadelphia, 2008
4) Gaudin PB, Reuter VE : Benign mimics of prostatic adenocarcinoma on needle biopsy. Anat Pathol 2 : 111-134, 1997
6) Uehara T, Hamano H, Kawakami M et al : Autoimmune pancreatitis-associated prostatitis : Distinct clinicopathologic entity. Pathol Int 58 : 118-125, 2008
7) Oppenheimer JR, Kahane H, Epstein JI : Granulomatous prostatitis on needle biopsy. Arch Pathol Lab Med 121 : 724-729, 1997
8) LaFontaine PD, Middleman BR, Graham SD et al : Incidence of granulomatous prostatitis and acid-fast bacilli after intravesical BCG therapy. Urology 49 : 363-366, 1997
9) Bostwick DG, Chang L : Overdiagnosis of prostatic adenocarcinoma. Sem Urol Oncol 17 : 199-205, 1999
10) Weaver MG, Abdul-Karim FW, Srigley J et al : Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study. Am J Surg Pathol 16 : 62-68, 1992
11) Cheng L, MacLennan GT, Abdul-karim FW et al : Eosinophilic metaplasia of the prostate. A newly described lesion distinct from other eosinophilic changes in prostatic epithelium. Anal Quant Cytol Histol 30 : 226-230, 2008
12) Sinowatz F, Amselgruber W, Plendl J et al : Effects of hormones on the prostate in adult and aging men and animals. Micro Res Tech 30 : 282-292, 1995
13) Civantos F, Soloway MS, Pinto JE : Histopathological effects of androgen deprivation in prostatic cancer. Sem Urol Oncol 14 : 22-31, 1996
14) Gal R, Koren R, Nofech-Mozes S et al : Evaluation of mucinous metaplasia of the prostate gland by mucin histochemistry. Br J Urol 77 : 113-117, 1996
15) Shiraishi T, Kusano I, Watanabe M et al : Mucous gland metaplasia of the prostate. Am J Surg Pathol 17 : 618-622, 1993
16) Grignon DJ, O'Malley FP. Mucinous metaplasia in the prostate gland. Am J Surg Pathol 17 : 287-290, 1993
18) Allan CH, Epstein JI : Nephrogenic adenoma of the prostatic urethra : a mimicker of prostate adenocarcinoma. Am J Surg Pathol 25 : 802-808, 2001
19) Malpica A, Ro JY, Troncoso P et al : Nephrogenic adenoma of the prostatic urethra involving the prostate gland : a clinicopathologic and immunohistochemical study of eight cases. Hum Pathol 24 : 390-395, 1994
20) Skinnider BF, Oliva E, Young RH et al : Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma : a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma. Am J Surg Pathol 28 : 701-705, 2004
23) De Marzo AM, Platz EA, Epstein JI et al : A working group classification of focal prostate atrophy lesions. Am J Surg Pathol 30 : 1281-1291, 2006
24) Wang W, Sun X, Epstein JI : Partial atrophy on prostate needle biopsy cores : a morphologic and immunohistochemical study. Am J Surg Pathol 32 : 851-857, 2008
25) Anton RC, Kattan MW, Chakraborty S et al : Postatrophic hyperplasia of the prostate : lack of association with prostate cancer. Am J Surg Pathol 23 : 932-936, 1999
28) Amin MB, Tamboli P, Varma M et al : Postatrophic hyperplasia of the prostate gland : a detailed analysis of its morphology in needle biopsy specimens. Am J Surg Pathol 23 : 925-931, 1999
31) Ayala AG, Srigley JR, Ro JY et al : Clear cell cribriform hyperplasia of prostate. Am J Surg Pathol 10 : 665-672, 1986
33) Devaraj LT, Bostwick DG : Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferation. Am J Surg Pathol 17 : 645-659, 1993
34) Rioux-Leclercq NC, Epstein JI : Unusual morphologic patterns of basal cell hyperplasia of the prostate. Am J Surg Pathol 26 : 237-243, 2002
35) McKenney JK, Amin MB, Srigley JR et al : Basal cell proliferations of the prostate other than usual basal cell hyperplasia : a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification. Am J Surg Pathol 28 : 1289-1298, 2004
36) Zhou M, Magi-Galluzzi C, Epstein JI : Prostate basal cell lesions can be negative for basal cell keratins. A diagnostic pitfall. Anal Quant Cytol Histol 28 : 125-129, 2006
38) Epstein JI : Adenosis vs. atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 18 : 1070-1071, 1994
39) Bostwick DG, Qian J : Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole mount radical prostatectomies. Am J Surg Pathol 19 : 506-518, 1995
40) Helpap B, Bostwick DG, Montirone R : The significance of atypical adenomatous hyperplasia (AAH) and prostatic intraepithelial neoplasia (PIN) for the development of prostatic carcinoma. An update. Virchow Arch 426 : 425-434, 1995
41) Gaudin PB, Epstein JI : Adenosis of the prostate. Histologic features in transurethral resection specimens. Am J Surg Pathol 18 : 863-870, 1994
42) Yang XJ, Wu CL, Woda BA et al : Expression of alphamethylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 26 : 921-925, 2002
44) Gaudin PB, Epstein JI : Adenosis of the prostate. Histologic features in needle biopsy specimens. Am J Surg Pathol 19 : 737-747, 1995
45) Cheng L, Shan A, Cheville JC et al : Atypical adenomatous hyperplasia of the prostate : a premalignant lesion? Cancer Res 58 : 389-391, 1998
46) Sakamoto N, Tsuneyoshi M, Enjoji M : Sclerosing adenosis of the prostate. Histopathologic and immunohistochemical analysis. Am J Surg Pathol 15 : 660-667, 1991
47) Jones EC, Clemint PB, Young RH : Sclerosing adenosis of the prostate gland. A clinicopathological and immunohistochemical study of 11 cases. Am J Surg Pathol 15 : 1171-1180, 1991
48) Grignon DJ, Ro JY, Srigley JR et al : Sclerosing adenosis of the prostate gland. A lesion showing myoepithelial differentiation. Am J Surg Pathol 16 : 383-391, 1992
50) Gikas PW, Del Buono EA, Epstein JI : Florid hyperplasia of mesonephric remnants involving prostate and periprostatic tissue. Possible confusion with adenocarcinoma. Am J Surg Pathol 17 : 454-460, 1993
52) Amin MB : Florid hyperplasia of mesonephroid remnants : Yet another differential diagnostic consideration under "small acinar proliferations of the prostate". Adv Anat Pathol 2 : 108-113, 1995
53) Jimenez RE, Raval MFT, Spanto R et al : Mesonephric remnant hyperplasia. Pitfall in the diagnosis of prostatic adenocarcinoma. J Urol Pathol 9 : 83-92, 1998
54) Gagucas RJ, Brown RW, Wheeler TM : Vermontanum mucosal gland hyperplasia. Am J Surg Pathol 19 : 30-36, 1995
56) Cina STJ, Siberman MA, Kahane H et al : Diagnosis of Cowper's glands on prostate needle biopsy. Am J Surg Pathol 21 : 550-555, 1997
57) Saboorian MH, Huffman H, Ashfaq R et al : Distinguishing Cowper's glands from neoplastic and pseudoneoplastic lesions of prostate. Immunohistochemical and ultrastructural studies. Am J Surg Pathol 21 : 1069-1074, 1997
58) Nelson RS, Epstein JI : Prostatic carcinoma with abundant xanthomatous cytoplasm. Foamy gland carcinoma. Am J Surg Pathol 20 : 419-426, 1996

第3部 鑑別ポイント

P.105 掲載の参考文献
1) Brawer MK, Peehl DM, Stamey TA et al : Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 45 : 3663-3667, 1985
2) Wojno KJ, Epstein JI : The utility of basal cell-specific anticytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases. Am J Surg Pathol 19 : 251-260, 1995
3) Yang XJ, Lecksell K, Gaudin P et al : Rare expression of high molecular-weight cytokeratin in adenocarcinoma of the prostate gland : a study of 100 cases of metastatic and locally advanced prostate cancer. Am J Surg Pathol 23 : 147-152, 1999
4) Abrahams NA, Ormsby AH, Brainard J : Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies. Histopathology 41 : 35-41, 2002
5) Reis-Filho JS, Simpson PT, Martins A et al : Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multitumor tissue microarray. Virchows Arch 443 : 122-132, 2003
9) Jiang Z, Woda BA, Rock KL et al : P504S ; a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 25 : 1397-1404, 2001
10) Yang XJ, Wu CL, Woda BA et al : Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 26 : 21-925, 2002
11) Gologan A, Bastacky S, McHale T et al : Age-associated changes in alpha-methyl CoA racemase (AMACR) expression in nonneoplastic prostatic tissues. Am J Surg Pathol 29 : 1435-1441, 2005
12) Shah RB, Zhou M, LeBlanc M et al : Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 26 : 1161-1168, 2002
13) Zhou M, Shah R, Shen R et al : Basal cell cocktail (34betaE12+p63) improves the detection of prostate basal cells. Am J Surg Pathol 27 : 365-371, 2003
14) Hameed O, Humphrey PA : p63/AMACR antibody cocktail restaining of prostate needle biopsy tissues after transfer to charged slides : a viable approach in the diagnosis of small atypical foci that are lost on block sectioning. Am J Clin Pathol 124 : 708-715, 2005
15) Hameed O, Sublett J, Humphrey PA : Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma : a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues. Am J Surg Pathol 29 : 579-587, 2005
18) Varma M, Linden MD, Amin MB : Effect of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues. Mod Pathol 12 : 472-478, 1999
19) Hameed O, Humphrey PA : Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol 22 : 88-104, 2005
20) Amin MB, Tamboli P, Varma M et al : Postatrophic hyperplasia of the prostate gland : a detailed analysis of its morphology in needle biopsy specimens. Am J Surg Pathol 23 : 925-931, 1999
21) Wang W, Sun X, Epstein JI : Partial atrophy on prostate needle biopsy cores : a morphologic and immunohistochemical study. Am J Surg Pathol 32 : 851-857, 2008
23) Oliai BR, Kahane H, Epstein JI : Can basal cells be seen in adenocarcinoma of the prostate? : an immunohistochemical study using high molecular weight cytokeratin (clone 34 betaE12) antibody. Am J Surg Pathol 26 : 1151-1160, 2002
24) McNeal JE, Yemoto CE : Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol 20 : 802-814, 1996
25) Guo CC, Epstein JI : Intraductal carcinoma of the prostate on needle biopsy : Histologic features and clinical significance. Mod Pathol 19 : 1528-1535, 2006
28) 鷹橋浩幸 : 稀な癌-導管型腺癌の診断上のポイント-. 病理と臨床 27 : 945-952, 2009
29) 小塚祐司, 鹿股直樹, 森谷卓也 : 前立腺病理における免疫染色の有用性と注意点. 病理と臨床 27 : 971-977, 2009
P.120 掲載の参考文献
1) Bailar JC 3rd, Mellinger GT, Gleason DF : Survival rates of patients with prostatic cancer, tumor stage, and differentiation : preliminary report. Cancer Chemother Rep 50 : 129-136, 1966
2) Gleason DF : Classification of prostatic carcinomas. Cancer Chemother Rep 50 : 125-128, 1966
3) Epstein JI, Allsbrook, WC, Amin MB et al : The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29 : 1228-1242, 2005
4) Epstein JI : Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy : a diagnosis that should not be made. Am J Surg Pathol 24 : 477-478, 2000
5) Makarov DV, Sanderson H, Partin AW et al : Gleason score 7 prostate cancer on needle biopsy : is the prognostic difference in Gleason scores 4+3 and 3+4 independent of the number of involved cores? J Urol 167 : 2440-2442, 2002
6) Grober ED, Tsihlias J, Jewett MA et al : Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors. Can J Urol 11 : 2157-2162, 2004
7) Merrich GS, Butler WM, Galbreath RW et al : Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy. Urology 60 : 98-103, 2002
8) Kunz GM Jr., Epstein JI : Should each core with prostate cancer be assigned a separate Gleason score? Hum Pathol 34 : 911-914, 2003
P.129 掲載の参考文献
1) 三上芳喜 : 針生検標本における異型病変の評価とピットフォール. 病理と臨床 23 : 373-378, 2005
4) Herawi M, Parwani AV, Irie J et al : Small glandular proliferations on needle biopsies. Most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion. Am J Surg Pathol 29 : 874-880, 2005
5) Gaudin PB, Epstein JI : Adenosis of the prostate. Histologic features in transurethral resection specimens. Am J Surg Pathol 18 : 863-870, 1994
P.135 掲載の参考文献
2) Helpap B : Observations on the number, size and localization of nucleoli in hyperplastic and neoplastic prostatic disease. Histopathology 13 : 203-211, 1988
3) Varma M, Lee MW, Tamboli P et al : Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice. Arch Pathol Lab Med 126 : 554-561, 2002
4) Buhmeida A, Kujari H, Collan Y : Nucleolar morphometry in fine needle aspiration biopsies of the prostate. Anal Quant Cytol Histol 23 : 185-192, 2001
5) Montironi R, Scarpelli M, Braccischi A et al : Quantitative analysis of nucleolar margination in diagnostic cytopathology. Virchows Arch A Pathol Anat Histopathol 419 : 505-512, 1991
7) Epstein JI : Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol 26 : 223-229, 1995
8) Thorson P, Vollmer RT, Arcangeli C et al : Minimal carcinoma in prostate needle biopsy specimens : diagnostic features and radical prostatectomy follow-up. Mod Pathol 11 : 543-551, 1998
9) Epstein JI, Armas OA : Atypical basal cell hyperplasia of the prostate. Am J Surg Pathol 16 : 1205-1214, 1992
10) Wang W, Sun X, Epstein JI : Partial atrophy on prostate needle biopsy cores : a morphologic and immunohistochemical study. Am J Surg Pathol 32 : 851-857, 2008
11) Gaudin PB, Epstein JI : Adenosis of the prostate. Histologic features in transurethral resection specimens. Am J Surg Pathol 18 : 863-870, 1994
12) Oppenheimer JR, Wills ML, Epstein JI : Partial atrophy in prostate needle cores : another diagnostic pitfall for the surgical pathologist. Am J Surg Pathol 22 : 440-445, 1998
13) Cheng L, Cheville JC, Bostwick DG : Diagnosis of prostate cancer in needle biopsies after radiation therapy. Am J Surg Pathol 23 : 1173-1183, 1999
14) Young RH : Nephrogenic adenomas of the urethra involving the prostate gland : a report of two cases of a lesion that may be confused with prostatic adenocarcinoma. Mod Pathol 5 : 617-620, 1992
15) Gikas PW, Del Buono EA, Epstein JI : Florid hyperplasia of mesonephric remnants involving prostate and periprostatic tissue. Possible confusion with adenocarcinoma. Am J Surg Pathol 17 : 454-460, 1993
16) Nelson RS, Epstein JI : Prostatic carcinoma with abundant xanthomatous cytoplasm. Foamy gland carcinoma. Am J Surg Pathol 20 : 419-426, 1996
18) Kramer CE, Epstein JI : Nucleoli in low-grade prostate adenocarcinoma and adenosis. Hum Pathol 24 : 618-623, 1993
19) Aihara M, Truong LD, Dunn JK et al : Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer. Hum Pathol 25 : 797-801, 1994
20) Vesalainen S, Lipponen P, Talja M et al : Mitotic activity and prognosis in prostatic adenocarcinoma. Prostate 26 : 80-86, 1995
21) Del Rosario AD, Bui HX, Abdulla M et al : Sulfur-rich prostatic intraluminal crystalloids : a surgical pathologic and electron probe x-ray microanalytic study. Hum Pathol 24 : 1159-1167, 1993
23) Holmes EJ : Crystalloids of prostatic carcinoma : relationship to Bence-Jones crystals. Cancer 39 : 2073-2080, 1977
24) Ro JY, Ayala AG, Ordonez NG et al : Intraluminal crystalloids in prostatic adenocarcinoma. Immunohistochemical, electron microscopic, and x-ray microanalytic studies. Cancer 57 : 2397-2407, 1986
25) Ro JY, Grignon DJ, Troncoso P et al : Intraluminal crystalloids in whole-organ sections of prostate. Prostate 13 : 233-239, 1988
26) Anton RC, Chakraborty S, Wheeler TM : The significance of intraluminal prostatic crystalloids in benign needle biopsies. Am J Surg Pathol 22 : 446-449, 1998
28) Henneberry JM, Kahane H, Humphrey PA et al : The significance of intraluminal crystalloids in benign prostatic glands on needle biopsy. Am J Surg Pathol 21 : 725-728, 1997.
29) Cohen RJ, McNeal JE, Redmond SL et al : Luminal contents of benign and malignant prostatic glands : correspondence to altered secretory mechanisms. Hum Pathol. 31 : 94-100, 2000
P.141 掲載の参考文献
1) Mahadevia PS, Koss LG, Tar IJ : Prostatic involvement in bladder cancer. Prostate mapping in 20 cystoprostatectomy specimens. Cancer 58 : 2096-2102, 1986
3) Esrig D, Freeman JA, Elmajian DA et al : Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 156 : 1071-1076, 1996
4) Ngninkeu BN, Lorge FM, Moulin P et al : Transitional cell carcinoma involving the prostate : a clinicopathological retrospective study of 76 cases. J Urol 169 : 149-152, 2003
7) Hameed O, Humphrey PA : Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol 22 : 88-104, 2005
9) Zhou M, Chinnaiyan AM, Kleer CG et al : Alpha-methylacyl-CoA racemase : a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 26 : 926-931, 2002

第4部 臨床との連携

P.148 掲載の参考文献
1) 坂本穆彦, 北川知之, 菅野晴夫 : 潜在癌. 代謝 25 (臨増) : 191-194, 1988
2) 日本泌尿器科学会 (編) : 前立腺がん検診ガイドライン, 2008年版, 金原出版, 2008
3) 坂本穆彦 : 標準病理学 (第3版), 医学書院, 2006, pp241-246
4) 日本泌尿器科学会・日本病理学会 (編) : 泌尿器科・病理 前立腺癌取扱い規約, 金原出版, 1985
5) 日本泌尿器科学会・日本病理学会 (編) : 泌尿器科・病理 前立腺癌取扱い規約 (第3版), 金原出版, 2001
6) 甲状腺外科検討会 (編) : 甲状腺癌取扱い規約 (第5版), 金原出版, 1996
7) Yatani R, Shiraishi T, Akazaki K et al : Incidental prostatic carcinoma : morphometry correlated with histological grade. Vinchows Arch A 409 : 395-405, 1985
8) 矢谷隆一, 高成秀樹, 白石泰三他 : 前立腺の微小癌. 病理と臨床 5 (臨増) : 269-277, 1987
9) Breslow N, Chan CW, Dhom G et al : Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 20 : 680-688, 1977
10) Sakr WA, Hass GP, Cassin BF et al : The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 150 : 379-385, 1993
11) Shiraishi T, Watanabe M, Matsuura H et al : The frequency of latent prostatic carcinoma in young males : the Japanese experience. In Vivo 8 : 445-447, 1994
12) Yatani R, Chigusa I, Akazaki K et al : Geographic pathology of latent prostatic carcinoma. Int J Cancer 29 : 611-616, 1982
13) 森脇昭介 : 骨転移の病理, 杏林書院, 2007, pp261-275
14) Bosland MC : The etiopathogenesis of prostatic cancer with special reference to environmental factors. Adv Cancer Res 51 : 1-106, 1988
15) McNeal JE, Redwine EA, Freiha FS et al : Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12 : 897-906, 1988
16) 小宮顕 : ラテント癌. 伊藤晴夫 (編) : "前立腺癌のすべて (改訂版)", メジカルビュー社, 2004, pp13-15
17) Stamey TA, Caldwekk M, McNeal JE, et al : The prostate specific antigen era in the United States is over for prostate cancer : what happened in the last 20 years? J Urol 172 : 1297-1301, 2004
18) Ohori M, Wheeler TM, Dunn JK et al : The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol 152 : 1714-1720, 1994
19) Graif Th, Yu X, Loeb St et al : Underdiagnosis and overdiagnosis of prostate cancer. J Urol 175 : No.4 Suppl, 2006
P.153 掲載の参考文献
1) Eble JN, Sauter G, Epstein JI et al (eds) : World Health Organization International Histological Classification of Tumours. Pathology and Genetics : Tumours of the Urinary System and Male Genital Organs, IARC press, Lyon, 2004
7) 日本泌尿器科学会・日本病理学会編 : 前立腺癌取扱い規約, 第3版, 金原出版, 2001
8) UICC : TNM Classification of Malignant Tumours, 6th ed, Wiley-Liss, New York, 2002
9) Amin MB, Grignon DJ, Humphrey PA et al : Reporting of prostate carcinoma by Gleason system. in "Gleason Grading of Prostate Cancer : A Contemporary Approach", Lippincott Williams & Wilkins, Philadelphia, 2004, pp101-111
10) Mostifi FK, Sesterhenn IA, Davis CJ : Histological Typing of Prostate Tumours, Springer, Berlin, 2002
14) Epstein JI, Netto GJ : Reporting cancer : influence on prognosis and treatment. in "Biopsy Interpretation of the Prostate, 4th ed", Lippincott Williams & Wilkins, Philadelphia, 2008, pp157-174
17) Murphy WM : ASAP is a bad idea. Atypical small acinar proliferation. Hum Pathol 30 : 601, 1999
18) van der Kwast TH, Lopes C, Santonja C et al : Guidelines for processing and reporting of prostatic needle biopsies. J Clin Pathol 56 : 336-340, 2003
19) Terakawa T, Miyake H, Kanomata N et al : Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL. Urology 72 : 1194-1197, 2008
20) Viglione MP, Potter S, Partin AW et al : Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy? Hum Pathol 33 : 796-800, 2002
21) 石田秀和, 中村光利, 島田啓司他 : 前立腺癌組織の三次元解析による腫瘍分布の検索 (会議録). 日本病理学会会誌 95 : 256, 2006
24) UICC : TNM Supplement. A Commentary on Uniform Use, Wiley-Liss, New York, 2003
25) Epstein JI : Pathological features that predict progression of disease following radical prostatectomy. in Foster CS, Bostwick DG (eds) : "Pathology of the Prostate", WB Saunders, Philadelphia, 1998, pp228-244
28) Jewett HJ : The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 2 : 105-124, 1975
30) Humphrey PA, Vollmer RT : Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod Pathol 10 : 326-333, 1997
P.159 掲載の参考文献
1) Mcleod DG : Hormonal therapy : historical perspective to future directions. Urology 61 : 3-7, 2003
2) Closset J, Ammar H, Nguyen VH et al : New features in the treatment of androgen- independent prostate cancer. Curr Pharm Des 10 : 513-522, 2004
3) van Tinteren H, Dalesio O : Systematic over view (metaanalysis) of all randomized trials of treatment of prostate cancer. Cancer 15 : 3847-3850, 1993
4) Nilsson S, Norlen BJ, Widmark A : A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 43 : 316-381, 2004
5) Zefelsky MJ, Wallner KE, Ling CC et al : Comparison of the 5-Year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early stage prostatic cancer. J Clin Oncol 17 : 517-522, 1999
7) 日本泌尿器科学会・日本病理学会編 : 泌尿器科・病理 前立腺癌取扱い規約, 第1版, 金原出版, 1985
8) 日本泌尿器科学会・日本病理学会前立腺癌取扱い規約作成委員会 : 前立腺癌組織学的治療効果判定基準. 癌の臨床 34 : 2027-2030, 1988
9) 日本泌尿器科学会・日本病理学会編 : 泌尿器科・病理 前立腺癌取扱い規約, 第3版, 金原出版, 2001
10) 坂本穆彦, 河合恒雄, 北川知行他 : 前立腺癌治療後の組織像の経時的変化. 癌の臨床 29 : 1433-1440, 1983
P.168 掲載の参考文献
1) Ohori M, Wheeler TM, Scardino PT : The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations. Cancer 74 : 104-114, 1994
2) Ohori M, Kattan MW, Utsunomiya T et al : Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible? J Urol 169 : 964-968, 2003
5) D'Amico AV, Whittington R, Malkowicz SB et al : Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 : 969-974, 1998
6) National Comprehensive Cancer Network Practice Guidelines in Oncology. Prostate Cancer V.I.2009. www.nccn.org
7) Kattan MW, Eastham JA, Stapleton AM et al : A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 : 766-771, 1998
8) Partin AW, Kattan MW, Subong EN et al : Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 : 1445-1451, 1997
9) Partin AW, Mangold LA, Lamm DM et al : Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58 : 843-848, 2001
11) Naito S, Kuroiwa K, Kinukawa N et al : Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading : data from the Clinicopathological Research Group for Localized Prostate Cancer. J Urol 180 : 904-909, 2008
14) Ohori M, Scardino PT, Lapin SL et al : The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol 17 : 1252-1261, 1993
17) Ohori M, Wheeler TM, Dunn JK et al : The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol 152 : 1714-1720, 1994
19) Albertsen PC, Hanley JA, Barrows GH et al : Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97 : 1248-1253, 2005

最近チェックした商品履歴

Loading...